Kaskela Law LLC Announces Investigation of Unum Therapeutics Inc. and Encourages Long-Term Investors to Contact the Firm - UMRX

PHILADELPHIA, July 21, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Unum Therapeutics Inc. (NASDAQ: UMRX) ("Unum" or the "Company") on behalf of the Company's investors. 

The investigation seeks to determine whether Unum and/or the Company's officers and directors have violated the securities laws in connection with recent corporate actions, and whether Unum investors have been harmed as a result.

Unum investors are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by email at skaskela@kaskelalaw.com or online at http://kaskelalaw.com/case/unum-therapeutics-inc/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.  For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.  This notice may constitute attorney advertising in certain jurisdictions.


D. Seamus Kaskela, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740

Cision View original content:http://www.prnewswire.com/news-releases/kaskela-law-llc-announces-investigation-of-unum-therapeutics-inc-and-encourages-long-term-investors-to-contact-the-firm--umrx-301096567.html

SOURCE Kaskela Law LLC

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.